Ignite Creation Date:
2025-12-24 @ 11:52 PM
Ignite Modification Date:
2026-02-22 @ 8:26 AM
Study NCT ID:
NCT01452451
Status:
COMPLETED
Last Update Posted:
2016-08-09
First Post:
2011-10-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety, Tolerability, Pharmacokinetics,Pharmacodynamics Study of LAPS-Exendin in Subjects of Type 2 Diabetes Mellitus
Sponsor:
Hanmi Pharmaceutical Company Limited
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-12
Start Date Type:
None
Primary Completion Date:
2013-06
Primary Completion Date Type:
ACTUAL
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2011-10-04
First Submit QC Date:
None
Study First Post Date:
2011-10-14
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2016-08-09
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2016-08-08
Last Update Post Date:
2016-08-09
Last Update Post Date Type:
ESTIMATED